Last Updated: April 23, 2026

Claims for Patent: 11,571,477

✉ Email this page to a colleague

Summary for Patent: 11,571,477

Title:	Anti-VLA-4 antibodies
Abstract:	This invention relates to alpha-4 binding antibodies, and fragments thereof.
Inventor(s):	Alexey A. Lugovskoy, Frederick R. Taylor, Karen McLachlan
Assignee:	Biogen MA Inc
Application Number:	US17/366,903

Details for Patent 11,571,477

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Auxilium Pharmaceuticals, Inc.	XIAFLEX	collagenase clostridium histolyticum	For Injection	125338	February 02, 2010	11,571,477	2041-07-02
Janssen Biotech, Inc.	SIMPONI ARIA	golimumab	Injection	125433	July 18, 2013	11,571,477	2041-07-02
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	October 21, 2013	11,571,477	2041-07-02
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	November 19, 2018	11,571,477	2041-07-02
Modernatx, Inc.	SPIKEVAX	covid-19 vaccine, mrna	Injection	125752	January 31, 2022	11,571,477	2041-07-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,571,477

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2011239512	⤷ Start Trial
Brazil	112012026403	⤷ Start Trial
Canada	2794863	⤷ Start Trial
China	103038257	⤷ Start Trial
Cyprus	1119154	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.